The Role of α-Linolenic Acid and Its Oxylipins in Human Cardiovascular Diseases
International Journal of Molecular Sciences · 24.03.2023 · 24 (7) · 6110
DOI: 10.3390/ijms24076110 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 24.03.2023. Verfasst von Lucia Cambiaggi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Chemistry and Biochemistry, Children's Research Center, University Children's Hospital Zurich, University of Zurich, 8032 Zurich…. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Fatty Acids, Omega-3. Die Arbeit wurde bisher 100-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss National Science Foundation.
Abstract (Originalsprache)
α-linolenic acid (ALA) is an essential C-18 n-3 polyunsaturated fatty acid (PUFA), which can be elongated to longer n-3 PUFAs, such as eicosapentaenoic acid (EPA). These long-chain n-3 PUFAs have anti-inflammatory and pro-resolution effects either directly or through their oxylipin metabolites. However, there is evidence that the conversion of ALA to the long-chain PUFAs is limited. On the other hand, there is evidence in humans that supplementation of ALA in the diet is associated with an improved lipid profile, a reduction in the inflammatory biomarker C-reactive protein (CRP) and a reduction in cardiovascular diseases (CVDs) and all-cause mortality. Studies investigating the cellular mechanism for these beneficial effects showed that ALA is metabolized to oxylipins through the Lipoxygenase (LOX), the Cyclooxygenase (COX) and the Cytochrome P450 (CYP450) pathways, leading to hydroperoxy-, epoxy-, mono- and dihydroxylated oxylipins. In several mouse and cell models, it has been shown that ALA and some of its oxylipins, including 9- and 13-hydroxy-octadecatrienoic acids (9-HOTrE and 13-HOTrE), have immunomodulating effects. Taken together, the current literature suggests a beneficial role for diets rich in ALA in human CVDs, however, it is not always clear whether the described effects are attributable to ALA, its oxylipins or other substances present in the supplemented diets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Clinical Chemistry and Biochemistry, Children's Research Center, University Children's Hospital Zurich, University of Zurich, 8032 Zurich, Switzerland.
- Center for Integrative Human Physiology, University of Zurich, 8032 Zurich, Switzerland.
ORCID-Profile: Nazek Noureddine, Martin Hersberger
Förderung
- Swiss National Science Foundation
Zitieren
APA
Cambiaggi, L., Chakravarty, A., Noureddine, N., & Hersberger, M. (2023). The Role of α-Linolenic Acid and Its Oxylipins in Human Cardiovascular Diseases. International Journal of Molecular Sciences, 24(7), 6110. https://doi.org/10.3390/ijms24076110
Vancouver
Cambiaggi L, Chakravarty A, Noureddine N, Hersberger M. The Role of α-Linolenic Acid and Its Oxylipins in Human Cardiovascular Diseases. International Journal of Molecular Sciences. 2023;24(7):6110. doi:10.3390/ijms24076110
BibTeX
@article{Cambiaggi2023,
author = {Cambiaggi, Lucia and Chakravarty, Akash and Noureddine, Nazek and Hersberger, Martin},
title = {The Role of α-Linolenic Acid and Its Oxylipins in Human Cardiovascular Diseases},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {7},
pages = {6110},
doi = {10.3390/ijms24076110}
}
EUVIMED